from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0509/hemA

LFCtreatmentdescriptionclass of inhibitor

-1.276

Amikacinug/mL Amikacintranslation

-2.304

Cap5-10ug/mL Capreomycintranslation

-3.049

Rox10-50 ug/mL Roxithromycintranslation

-0.021

SM2-5 ug/mL Streptomycintranslation

-1.907

Tet5-10 ug/mL Tetracyclinetranslation

-0.702

Rif0.2-5ug/mL Rifampicintranscription

1.361

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.044

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.834

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.246

CPZ10-50 ug/mL Chlorpromazinerespiration

0.637

Clofazimine10-13 ug/mL Clofaziminerespiration

0.749

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.999

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.744

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.968

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.955

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.163

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.171

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.626

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.121

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.053

KCN5-20 ug/mL Potassium cyaniderespiration

0.195

NaN30.2-2 mM Sodium aziderespiration

-0.335

Nigericin50 uM Nigericinrespiration

-0.225

TRC10-150 ug/mL Triclosanrespiration

-0.344

TRZ10-25 ug/mL Thioridazinerespiration

-1.279

Valinomycin0.5-10 uM Valinomycinrespiration

-0.762

ZnSO42 mM ZnSO4respiration

-0.197

menadione6-10 ug/mL Menadionerespiration

0.776

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.022

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.538

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.507

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.436

NRP_1Non-replicating persistence stage 1dosRassociated

-0.279

Amp0.2mg/mL AmpicillincellWall

-0.147

Cephalexin20-100 ug/mL CephalexincellWall

0.244

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.240

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.310

EMB10-20 ug/mL EthambutolcellWall

1.030

Eta12-40 ug/mL EthionamidecellWall

0.930

INH0.2-0.4 ug/mL IsoniazidcellWall

0.599

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.004

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.451

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.254

BZA0.12 mg/mL BenzamidearomaticAmides

-0.479

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.372

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.010

H2O24 mM hydrogen peroxideDNAdamaging

0.299

Levo10 ug/mL LevofloxacinDNAdamaging

0.113

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.945

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.022

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.244

UVUV-irradiationDNAdamaging

-0.443

ARP41-4 ug/mL Antitubercular compound ARP4?

0.812

Antimycin12.5-50 ug/mL Antimycin A?

-0.222

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.161

PA_110-50 ug/mL Antitubercular compound PA-1?

0.677

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.205

PA8240.2-2 ug/mL PA-824?

0.692

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.055

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.552

Verapamil50 uM Verapamil?

0.624

mercaptoethanol2 mM 2-Mercaptoethanol?

0.008

methoxatin10-20 ug/mL Methoxatin?